Skip to main content

Remote Job Finders (RJF)

Alector Cuts Staff Again, This Time Laying Off 13% of Workforce

As part of cost-cutting efforts, Alector is letting go of about 25 people as it focuses on advancing its preclinical and research pipeline. Alector is also continuing clinical-stage work on programs for frontotemporal dementia and Alzheimer’s disease.

Average Life Sciences Salaries Up 9% in 2024, but Bonuses and Equity Values Drop: BioSpace Report

The 9% average salary increase from 2023 to 2024 was the largest for life sciences professionals since 2021. Several factors could be behind the spike, including companies providing higher pay because bonuses and stock compensation went down.

AstraZeneca Makes Potential $10B+ China Commitment Despite Political Pressure

The investments come amid an ongoing insurance fraud probe into AstraZeneca’s former China head Leon Wang—and despite mounting pressure from President Trump for pharma companies to re-shore their manufacturing operations.

AbbVie Lawsuit Alleges That Partner Genmab “Misappropriated” Trade Secrets

AbbVie claims that Genmab turned a blind eye to trade secret theft allegedly used to support the development of ProfoundBio’s investigational antibody-drug conjugates. Genmab acquired ProfoundBio in May 2024.

J&J Joins Pharma Peers With $55B US Manufacturing Boost Following Trump’s Tariff Threats

Johnson & Johnson follows Eli Lilly in spending billions on U.S. manufacturing after President Donald Trump threatened major tariffs on pharmaceutical products. Pfizer has also promised a similar commitment.
Scroll to top